Shanghai Pharmaceuticals Holding Co (HKSE:02607) Change In Receivables : HK$0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Shanghai Pharmaceuticals Holding Co Change In Receivables?

Shanghai Pharmaceuticals Holding Co's change in receivables for the quarter that ended in Mar. 2024 was HK$0 Mil. It means Shanghai Pharmaceuticals Holding Co's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Shanghai Pharmaceuticals Holding Co's change in receivables for the fiscal year that ended in Dec. 2023 was HK$-7,036 Mil. It means Shanghai Pharmaceuticals Holding Co's Accounts Receivable increased by HK$7,036 Mil from Dec. 2022 to Dec. 2023 .

Shanghai Pharmaceuticals Holding Co's Accounts Receivable for the quarter that ended in Mar. 2024 was HK$88,258 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Shanghai Pharmaceuticals Holding Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 105.68.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Shanghai Pharmaceuticals Holding Co's liquidation value for the three months ended in Mar. 2024 was HK$-22,055 Mil.

Shanghai Pharmaceuticals Holding Co Change In Receivables Historical Data

The historical data trend for Shanghai Pharmaceuticals Holding Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Pharmaceuticals Holding Co Change In Receivables Chart

Shanghai Pharmaceuticals Holding Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-5,656.82

-4,827.28

-7,537.22

-11,258.07

-7,035.64

Shanghai Pharmaceuticals Holding Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Shanghai Pharmaceuticals Holding Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0 Mil.

Shanghai Pharmaceuticals Holding Co (HKSE:02607) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Shanghai Pharmaceuticals Holding Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	88257.679	/	76207.075	*	91
=	105.68

2. In Ben Graham's calculation of liquidation value, Shanghai Pharmaceuticals Holding Co's accounts receivable are only considered to be worth 75% of book value:

Shanghai Pharmaceuticals Holding Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	40383.584	-	147010.599	+	0.75 * 88257.679	+	0.5 * 36758.368
=	-22,055

Shanghai Pharmaceuticals Holding Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Shanghai Pharmaceuticals Holding Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Pharmaceuticals Holding Co (HKSE:02607) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Shanghai Pharmaceuticals Holding Co Ltd (HKSE:02607) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

SHPMY:USA SHPMF:USA S1R:Germany 601607:China

Address

No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020

Website

https://www.sphchina.com

Shanghai Pharmaceuticals Holding is a vertically integrated Chinese healthcare company that operates drug manufacturing, distribution, and retail pharmacy businesses in mainland China. It is the second-largest distributor by revenue and has a strong distribution presence in Eastern China.

Executives

Blackrock, Inc.	2201 Interest of corporation controlled by you
Shanghai Industrial Investment (holdings) Company Limited	2201 Interest of corporation controlled by you
Siic International Investment Company Limited	2101 Beneficial owner
Citigroup Inc.	2201 Interest of corporation controlled by you
Lsv Asset Management	2102 Investment manager

Shanghai Pharmaceuticals Holding Co (HKSE:02607) Headlines

No Headlines